REQUEST A DEMO
Total
USD $0.00
Search more companies

Neuraxpharm Bohemia S.R.O. (Czech Republic)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Secondary Activities: General Warehousing and Storage | Lessors of Other Real Estate Property | Professional, Scientific, and Technical Services | Research and Development in Nanotechnology | All Other Business Support Services
Full name: Neuraxpharm Bohemia S.R.O. Profile Updated: October 06, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Neuraxpharm Bohemia S.R.O. is an enterprise based in Czech Republic. Its main office is in Prague. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. Neuraxpharm Bohemia S.R.O. was incorporated on March 29, 2018. 25 - 49 (2023) employees currently work for Neuraxpharm Bohemia S.R.O.. Its total assets grew by 24.94% over the same period.

Headquarters
namesti Republiky 1078/1
Prague; The City of Prague; Postal Code: 11000

Contact Details: Purchase the Neuraxpharm Bohemia S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Neuraxpharm Bohemia S.R.O. report to view the information.
Registered Capital:
Purchase the Neuraxpharm Bohemia S.R.O. report to view the information.
Financial Auditors:
Purchase the Neuraxpharm Bohemia S.R.O. report to view the information.
Incorporation Date:
March 29, 2018
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Neuraxpharm Bohemia S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
EBITDA
N/A
Total assets
24.94%
Total equity
-25.17%
Debt to Equity Ratio
18.63%
Quick Ratio
-0.37%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?